Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 5.80%599.35M | -9.92%262.89M | -0.72%566.48M | 16.02%291.83M | 13.79%570.57M | 25.93%251.53M | 114.34%501.44M | 113.58%199.74M | 74.01%233.95M | 87.37%93.52M |
| Operating income | 5.80%599.35M | -9.92%262.89M | -0.72%566.48M | 16.02%291.83M | 13.79%570.57M | 25.93%251.53M | 114.34%501.44M | 113.58%199.74M | 74.01%233.95M | 87.37%93.52M |
| Cost of sales | -1.62%-314.18M | 10.09%-136.81M | 8.31%-309.18M | -8.95%-152.17M | -9.57%-337.19M | 2.12%-139.66M | -57.76%-307.74M | -84.75%-142.68M | -89.68%-195.07M | -104.62%-77.23M |
| Operating expenses | -1.62%-314.18M | 10.09%-136.81M | 8.31%-309.18M | -8.95%-152.17M | -9.57%-337.19M | 2.12%-139.66M | -57.76%-307.74M | -84.75%-142.68M | -89.68%-195.07M | -104.62%-77.23M |
| Gross profit | 10.83%285.17M | -9.73%126.08M | 10.25%257.3M | 24.85%139.66M | 20.49%233.38M | 96.07%111.87M | 398.26%193.7M | 250.33%57.05M | 23.03%38.88M | 33.85%16.29M |
| Selling expenses | -19.62%-218.17M | 6.25%-92.59M | -11.79%-182.38M | -109.57%-98.76M | -111.60%-163.15M | -298.96%-47.13M | -834.32%-77.1M | -298.78%-11.81M | -15.77%-8.25M | -29.68%-2.96M |
| Administrative expenses | -5.54%-35.12M | -3.33%-17.18M | 5.20%-33.28M | -17.53%-16.63M | -13.61%-35.1M | -3.84%-14.15M | -29.35%-30.9M | -56.98%-13.63M | -23.30%-23.89M | -15.81%-8.68M |
| Profit from asset sales | 142.63%434K | ---- | -125.25%-1.02M | ---- | 138.71%4.03M | ---- | -491.15%-10.42M | ---- | ---1.76M | ---- |
| Revaluation surplus | 621.78%5.06M | 95.89%-131K | 55.57%-969K | -213.16%-3.19M | 79.40%-2.18M | 115.44%2.82M | 9.53%-10.59M | -2,943.30%-18.25M | ---11.7M | --642K |
| -Changes in the fair value of financial assets | 621.78%5.06M | 95.89%-131K | 55.57%-969K | -213.16%-3.19M | 79.40%-2.18M | 115.44%2.82M | 9.53%-10.59M | -2,943.30%-18.25M | ---11.7M | --642K |
| Impairment and provision | -342.00%-30.84M | ---- | -71.83%-6.98M | ---- | -81.38%-4.06M | -518.45%-1.41M | -365.49%-2.24M | 151.61%336K | 79.55%-481K | ---651K |
| -Other impairment is provision | -342.00%-30.84M | ---- | -71.83%-6.98M | ---- | -81.38%-4.06M | -518.45%-1.41M | -365.49%-2.24M | 151.61%336K | 79.55%-481K | ---651K |
| Special items of operating profit | -9.12%3.92M | -13.39%2.34M | 23.62%4.31M | 845.96%2.7M | 405.81%3.49M | -69.62%285K | -88.06%689K | -80.37%938K | 10.96%5.77M | 161.45%4.78M |
| Operating profit | -71.77%10.44M | -22.17%18.51M | 1.58%36.98M | -54.53%23.78M | -42.35%36.41M | 257.28%52.29M | 4,485.21%63.15M | 55.49%14.64M | -118.13%-1.44M | 274.74%9.41M |
| Financing cost | -28.14%-1.79M | -84.97%-960K | -103.49%-1.4M | -78.35%-519K | -70.72%-688K | -293.24%-291K | ---403K | ---74K | ---- | ---- |
| Share of profits of associates | -25.32%-99K | -44.74%-55K | 3.66%-79K | 2.56%-38K | -6.49%-82K | -11.43%-39K | -113.89%-77K | ---35K | ---36K | ---- |
| Earning before tax | -75.93%8.55M | -24.67%17.49M | -0.37%35.5M | -55.31%23.22M | -43.13%35.64M | 257.69%51.96M | 4,345.73%62.67M | 54.33%14.53M | 47.06%-1.48M | 262.21%9.41M |
| Tax | -88.03%-10.32M | 19.82%-2.16M | 49.00%-5.49M | 78.50%-2.69M | 53.30%-10.76M | -58.89%-12.51M | -1,950.62%-23.05M | -1,713.82%-7.87M | -204.61%-1.12M | 49.83%-434K |
| After-tax profit from continuing operations | -105.91%-1.77M | -25.31%15.33M | 20.67%30.02M | -47.96%20.53M | -37.22%24.87M | 492.83%39.45M | 1,623.77%39.62M | -25.88%6.66M | 17.64%-2.6M | 234.66%8.98M |
| Earning after tax | -105.91%-1.77M | -25.31%15.33M | 20.67%30.02M | -47.96%20.53M | -37.22%24.87M | 492.83%39.45M | 1,623.77%39.62M | -25.88%6.66M | 17.64%-2.6M | 234.66%8.98M |
| Minority profit | -28,346.67%-4.27M | 20,471.43%1.43M | -100.28%-15K | -100.07%-7K | -69.48%5.42M | 65.47%10.59M | --17.77M | --6.4M | ---- | ---- |
| Profit attributable to shareholders | -91.70%2.49M | -32.28%13.91M | 54.39%30.03M | -28.85%20.54M | -10.98%19.45M | 11,131.91%28.87M | 940.42%21.85M | -97.14%257K | 17.64%-2.6M | 234.66%8.98M |
| Basic earnings per share | -91.61%0.0035 | -32.28%0.0193 | 1.46%0.0417 | -53.28%0.0285 | -55.03%0.0411 | 5,445.45%0.061 | 4,073.91%0.0914 | -86.59%0.0011 | 30.30%-0.0023 | 210.81%0.0082 |
| Diluted earnings per share | -91.61%0.0035 | -32.28%0.0193 | 1.46%0.0417 | -53.28%0.0285 | 0.0411 | 5,445.45%0.061 | -86.59%0.0011 | 210.81%0.0082 | ||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | Zhongrui Hexin Certified Public Accountants Co., Ltd. | -- | Zhongrui Hexin Certified Public Accountants Co., Ltd. | -- | Zhongrui Hexin Certified Public Accountants Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.